Establishment of lethal inhalational infection with Francisella tularensis (tularaemia) in the common marmoset (Callithrix jacchus)

Susceptibility and lethality studies of inhalational tularaemia were undertaken using the common marmoset (Callithrix jacchus) to determine its suitability as a non‐human primate model. Pairs of marmosets were exposed to varying challenge doses of Francisella tularensis by the airborne route and monitored for up to 14 days postchallenge (p.c.). Lethal infection was achieved following a retained dose of less than 10 bacterial colony‐forming units (CFU). However, precise LD50 determination was not possible. The model was characterized using a target challenge dose of approximately 100 CFU. Increased core body temperature was the first indicator of disease, at approximately 2.5 days p.c. Overt clinical signs were first observed 12–18 h after the temperature increase. Significantly decreased activity was observed after approximately 3 days. All animals succumbed to infection between 4.5 and 7 days p.c. At postmortem examination, gross pathology was evident in the liver, spleen and lungs of all animals and high bacterial numbers were detected in all the organs assessed. Bacteraemia was demonstrated in all animals postmortem. Histopathological observations included severe suppurative bronchopneumonia, severe multifocal pyogranulomatous hepatitis, splenitis and lymphadenitis. Tularaemia disease progression in the common marmoset therefore appears to be consistent with the disease seen in humans and other animal models. The common marmoset may therefore be considered a suitable model for further studies of inhalational tularaemia.

[1]  P. Pearce,et al.  Experimental respiratory anthrax infection in the common marmoset (Callithrix jacchus) , 2008, International journal of experimental pathology.

[2]  Terry H. Wu,et al.  Animal Models of Francisella tularensis Infection , 2007, Annals of the New York Academy of Sciences.

[3]  R. Grunow,et al.  Re-emergence of Francisella tularensis in Germany: fatal tularaemia in a colony of semi-free-living marmosets (Callithrix jacchus) , 2007, Epidemiology and Infection.

[4]  E. Williamson,et al.  A biocompatible microdevice for core body temperature monitoring in the early diagnosis of infectious disease , 2007, Biomedical microdevices.

[5]  K. E. Williams,et al.  A novel method for activity monitoring in small non-human primates , 2005, Laboratory animals.

[6]  D. Page,et al.  Histologic and molecular diagnosis of tularemia: a potential bioterrorism agent endemic to North America , 2004, Modern Pathology.

[7]  Wangxue Chen,et al.  Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background. , 2003, Vaccine.

[8]  Wangxue Chen,et al.  Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis: bacteriologic and histopathologic studies. , 2003, Microbial pathogenesis.

[9]  A. Tärnvik,et al.  Tularaemia , 2003, European Respiratory Journal.

[10]  C. Chae,et al.  Expression of Cyclooxygenase-2 in Swine Naturally Infected with Actinobacillus pleuropneumoniae , 2003, Veterinary pathology.

[11]  G. Martin,et al.  Clinicopathologic aspects of bacterial agents. , 2001, Clinics in laboratory medicine.

[12]  Philip K. Russell,et al.  Tularemia as a biological weapon: medical and public health management. , 2001, JAMA.

[13]  M. Welle,et al.  Tularemia in a common marmoset (Callithrix jacchus) diagnosed by 16S rRNA sequencing. , 1998, Veterinary microbiology.

[14]  A. Sjöstedt,et al.  Neutrophils are critical for host defense against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection , 1994, Infection and immunity.

[15]  W. J. Dixon,et al.  Application of Staircase Bioassays in Pharmaceutical Research , 1993 .

[16]  P. Nieminen,et al.  Bronchial changes in airborne tularemia , 1986, The Journal of Laryngology & Otology.

[17]  W Schaffner,et al.  Tularemia: A 30‐Year Experience With 88 Cases , 1985, Medicine.

[18]  P. Hambleton,et al.  The pathology of untreated and antibiotic-treated experimental tularaemia in monkeys. , 1978, British journal of experimental pathology.

[19]  C. Hetherington Circadian oscillations of body temperature in the marmoset, Callithrix jacchus , 1978, Laboratory animals.

[20]  R. Kovatch,et al.  The Journal of Pathology , 2022 .

[21]  W. Hall,et al.  Pathogenesis of Tularemia in Monkeys Aerogenically Exposed to Francisella tularensis 425 , 1972, Infection and immunity.

[22]  W. Day,et al.  Experimental Tularemia in Macaca mulatta: Relationship of Aerosol Particle Size to the Infectivity of Airborne Pasteurella tularensis , 1972, Infection and immunity.

[23]  H. T. Eigelsbach,et al.  Host-parasite relationship in monkeys administered live tularemia vaccine. , 1970, The American journal of pathology.

[24]  H. T. Eigelsbach,et al.  Oral Vaccination against Tularemia in the Monkey 1 , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[25]  H. A. Druett A mobile form of the Henderson apparatus , 1969, Journal of Hygiene.

[26]  M. Finegold,et al.  Studies on the pathogenesis of plague. Blood coagulation and tissue responses of Macaca mulatta following exposure to aerosols of Pasteurella pestis. , 1968, The American journal of pathology.

[27]  A. Hogge,et al.  Antibiotic prophylaxis and therapy of airborne tularemia. , 1966, Bacteriological reviews.

[28]  J. D. White,et al.  LIVE TULAREMIA VACCINE I , 1962, Journal of bacteriology.

[29]  H. Wilson,et al.  Tularemia vaccine study. II. Respiratory challenge. , 1961, Archives of internal medicine.

[30]  B. M. Stuart,et al.  TULAREMIC PNEUMONIA: REVIEW OF AMERICAN LITERATURE AND REPORT OF 15 ADDITIONAL CASES , 1945 .